Randall Kaye

Randall Kaye

Chief Tech/Sci/R&D Officer at LONGBOARD PHARMACEUTICALS, INC.

Net worth: 15 000 $ as of 29/04/2024

61 year
Health Technology
Technology Services
Consumer Services

Randall Kaye active positions

CompaniesPositionStartEnd
NERVGEN PHARMA CORP. Director/Board Member 27/10/2020 -
Independent Dir/Board Member 27/10/2020 -
LONGBOARD PHARMACEUTICALS, INC. Chief Tech/Sci/R&D Officer 20/03/2022 -

Career history of Randall Kaye

Former positions of Randall Kaye

CompaniesPositionStartEnd
Chief Tech/Sci/R&D Officer 31/08/2018 31/08/2019
Corporate Officer/Principal 31/08/2014 31/08/2018
AXSOME THERAPEUTICS, INC. Chief Tech/Sci/R&D Officer 31/08/2014 31/08/2016
AVANIR PHARMACEUTICALS INC Chief Tech/Sci/R&D Officer 31/12/2005 31/08/2014
Chief Tech/Sci/R&D Officer 31/12/2003 31/12/2005
INTERMUNE INC Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 27/10/2020 -

Training of Randall Kaye

George Washington University Doctorate Degree

Statistics

International

United States 10
Canada 2

Operational

Chief Tech/Sci/R&D Officer 7
Doctorate Degree 1
Graduate Degree 1

Sectoral

Health Technology 8
Technology Services 2
Consumer Services 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies3
AXSOME THERAPEUTICS, INC.

Health Technology

NERVGEN PHARMA CORP.

Health Technology

LONGBOARD PHARMACEUTICALS, INC.

Health Technology

Private companies6

Health Technology

Health Technology

Health Technology

Technology Services

Commercial Services

Health Technology

See company connections